Glioblastoma (GBM) is an aggressive type of brain cancer that is known to be very difficult to treat. One reason why this ...
Morning Overview on MSN
New combination therapy achieves unprecedented remission in glioblastoma brain cancer models
Glioblastoma is the most aggressive primary brain cancer in adults, killing most patients within two years of diagnosis ...
The emergence of vorasidenib, the first targeted therapy for certain gliomas with IDH mutations, has ignited a wave of excitement in both patient and physician spaces. But following the approval, some ...
The genes encoding IDH1/2 and BRAF are frequently altered in low-grade glioma; the presence or absence of these alterations should be determined in all patients. Maximal safe tumor resection remains ...
An AI tool using temporal learning significantly outperforms traditional methods in predicting pediatric glioma recurrence, achieving 75% to 89% accuracy. The AI model analyzes multiple brain scans ...
Artificial intelligence (AI) shows tremendous promise for analyzing vast medical imaging datasets and identifying patterns that may be missed by human observers. AI-assisted interpretation of brain ...
As of January 22, 2026, the study has enrolled 23 patients with recurrent or progressive GBM who progressed following standard-of-care therapy, including surgery, radiation, and temozolomide-based ...
Artificial intelligence (AI) shows tremendous promise for analyzing vast medical imaging datasets and identifying patterns that may be missed by human observers. AI-assisted interpretation of brain ...
Please provide your email address to receive an email when new articles are posted on . A patient’s frailty should be considered when determining fractionation for WHO grade 4 adult-type diffuse ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results